NEW YORK, Sept 21 – The US National Cancer Institute (NCI) has purchased Nanogen’s (Nasdaq: NGEN) NanoChip system for use in cancer research and diagnosis, Nanogen said Thursday.

“The NanoChip system may accelerate this process, allowing us to potentially use this same tool in both the research process and in the patient care process,” Stephen Chanock of the NCI’s Pediatric Oncology Branch at the Advanced Technology Center said in a statement.

Terms of the deal were not disclosed. Representatives of NCI and Nanogen could not immediately be reached for comment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.